• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
TANG Yi,YAN Chulin,DAI Xinli,ZENG Yizhen,QU Bangchen,TAO Liang.Research progress on the role of natural compounds in regulating ferroptosis in metabolic associated fatty liver disease[J].Journal Of Pharmaceutical Research,2026,45(1):63-71,102[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2780times   Download 820次 QR Code for this article
Scan with your phone!
天然化合物调节铁死亡在代谢相关脂肪性肝病中的作用研究进展
唐怡,颜楚林,戴欣黎,曾奕臻,瞿邦宸,陶亮
Font:Larger+|Default|Smaller-
(南华大学衡阳医学院,湖南 衡阳 421001)
摘要:
铁死亡作为一种铁依赖性脂质过氧化驱动的程序性细胞死亡形式,在代谢相关脂肪性肝病(metabolic associated fatty liver disease, MAFLD)的病理进程中发挥关键作用。MAFLD以肝脏脂质代谢紊乱为核心特征,其进展与铁过载、脂质过氧化及氧化应激密切相关,而铁死亡调控失衡可进一步加剧肝脏损伤和炎症反应。尽管目前尚无特异性靶向铁死亡的临床药物获批上市,但天然化合物因其多靶点调控特性,展现出了干预铁死亡从而缓解MAFLD的明显潜力。本综述将聚焦天然化合物对铁死亡关键节点与天然化合物的精准调控,结合多项实验性研究,为MAFLD的靶向治疗提供创新策略。
关键词:  天然化合物  铁死亡  代谢相关脂肪性肝病
DOI:10.13506/j.cnki.jpr.2026.01.010
基金项目:国家自然科学基金项目(No.82400693);湖南省自然科学基金项目(No.2023JJ40567);南华大学大学生创新创业训练计划项目(No.D202305162239264716)
Publication Date:January 26, 2026
Research progress on the role of natural compounds in regulating ferroptosis in metabolic associated fatty liver disease
TANG Yi,YAN Chulin,DAI Xinli,ZENG Yizhen,QU Bangchen,TAO Liang
(Hengyang Medical School, University of South China, Hengyang 421001, China)
Abstract:
Ferroptosis is an iron-dependent programmed cell death form driven by lipid peroxidation, plays a pivotal role in the pathogenesis of metabolic associated fatty liver disease(MAFLD). MAFLD is characterized by hepatic lipid metabolism disorder, with disease progression strongly associated with iron overload, lipid peroxidation, and oxidative stress—where the imbalance in ferroptosis regulation could additionally exacerbate hepatic injury and inflammatory responses. Although there are no clinical drugs specifically targeting ferroptosis approved for market currently, natural compounds demonstrate significant potential in intervening ferroptosis to alleviate MAFLD due to their multi-target regulatory properties. This review focuses on precisely regulating key ferroptosis pathways by natural compounds, integrating multiple experimental studies to propose innovative strategies for targeted MAFLD therapy.
Key words:  Natural compounds  Ferroptosis  Metabolic associated fatty liver disease
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.